Toolbox COVID-19

COVID-19

The COVID-19 TOOLBOX is a comprehensive knoweledge repository collating practical, up-to-date information on the emerging coronavirus. It brings together key documents, guidelines, posters training tools as well as information sources for various disciplines and backgrounds including, among others, clinicians, public health, authorities and the general public.

Our Recommendations

New Publications

Countering Stigmatization in the Humanitarian Response to COVID-19_szafeczka (2024)
Mexico: a primary health care case study in the context of the COVID-19 pandemic (2024)
Apéndice. Lograr una mejor inmunidad: El enfoque del curso de vida para una longevidad saludable (2024)
A checklist for respiratory pathogen pandemic preparedness planning (2023)
Conditions for health system resilience in the response to the COVID-19 pandemic in Mauritania (2023)

Filter

4316

Sort by:

Direction:

Download (132)

View PDF (153)

Save to learn during COVID-19: Recommendations to prevent and respond to violence against children in all learning environments

UNICEF (2020) C_UNICEF

Many children will not be ‘safe to learn at home’: As of April 2020, 91 percent of the world’s students have been affected by school closures due to COVID-19. While schools are often places where violence occurs, they also offer a comparatively protective and nurturing space for many children.... more

Download (88)

View PDF (146)

Considerations and Principles for Shielding People at High Risk of Severe Outcomes from COVID-19

Social Science in Humanitarian Action (2020) CC

This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline... more

Download (145)

View PDF (192)

Consejos sobre la utilización de mascarillas en el entorno comunitario, en la atención domiciliaria y en centros de saluden el contexto del brote de nuevo coronavirus (2019-nCoV)

World Health Organization (WHO) OMS (2020) CC

El presente documento contiene directrices provisionales sobre la utilización de mascarillas en comunidades que han notificado la aparición de brotes causados por el nuevo coronavirus (2019-nCoV). Está dirigido a profesionales, coordinadores sanitarios, trabajadores sanitarios y... more

Download (111)

View PDF (180)

Recomendaciones importantes sobre el agua, el saneamiento y la higiene COVID-19 en la comunidad

World Health Organization (WHO) (2020) CC

Las mejores prácticas de agua, saneamiento e higiene, en particular el lavado de manos con jabón y agua limpia, deben aplicarse y mantenerse estrictamente, ya que constituyen una barrera adicional importante para la transmisión de COVID-19 y para la transmisión de enfermedades infecciosas en gen... more

Download (147)

View PDF (158)

Uso racional del equipo de protección personal frente a la COVID-19 y aspectos que considerar en situaciones de escasez graves
recommended

Organización Mundial de la Salud OMS (2021) C_WHO

orientaciones provisionales, 23 de diciembre de 2020 En este documento se resumen las recomendaciones de la OMS para utilizar de forma racional los equipos de protección personal (EPP) tanto en los centros sanitarioscomo en los domicilios, así como durante la manipulación... more

Download (197)

View PDF (240)

Countering Stigmatization in the Humanitarian Response to COVID-19_szafeczka

test_test (2024) CC

In most contexts, the social stigma surrounding mental health issues exists because of cultural norms and a lack of understanding of mental health’s complexities and realities, resulting in isolation, increased vulnerability, and lack of support for people with mental health problems. This stig... more

Download (106)

View PDF (149)

WHO strategic action and resource requirements to end the acute phase of the COVID-19 pandemic 2021

World Health Organization WHO (2021) C_WHO

WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI... more

Download (118)

View PDF (162)

Global spending on health: rising to the pandemic’s challenges

World Health Organization WHO (2022) C_WHO

The results of the report clearly show that in 2020, a year dominated by the emergence of COVID-19 and its associated health and economic crises, governments around the world rose to the challenge. Sharp increases in government spending on health at all country income levels underpinned the rise in ... more

Download (94)

View PDF (102)

The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond

World Health Organisation (WHO) (2023) C_WHO

The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan... more

Download (97)

View PDF (98)

Dépistage de la Covid-19 chez les Femmes Enceintes et les Accouchées dans Six Maternités de Brazzaville

World Health Organisation (WHO) (2023) CC

La prévalence de la covid -19 chez la femme enceinte et les accouchées semble être faible. Elles étaient asymptomatiques et le pronostic maternel était satisfaisant. Néanmoins, le risque de for.pdf

Download (93)

View PDF (101)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 10 August 2023

World Health Organization WHO (2023) C_WHO

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... more

Download (77)

View PDF (105)

Clinical management of COVID-19: Living guideline, 18 August 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

Download (89)

View PDF (99)

Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage

World Health Organisation (WHO) (2023) C_WHO

Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ... more

Download (124)

View PDF (126)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 9 October 2023

World Health Organization WHO (2023) CC

Download (188)

View PDF (217)

Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit

Bangladesh Red Crescent Society; BRAC; Government of Bangladesh; UN Children's Fund UNICEF; UN Women; World Health Organization WHO (2023) CC

This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health and Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, w... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (50)

View PDF (228)

Conditions for health system resilience in the response to the COVID-19 pandemic in Mauritania

Accoe K.; Kriel B.; Ag Ahmed M. et al. BMJ Global Health (2023) CC

A country’s ability to manage a crisis depends on its level of resilience. Efforts are made to clarify the concept of health system resilience, but its operationalisation remains little studied. In the present research, we described the capacity of the local healthcare system in the Islamic Republ... more

Download (151)

View PDF (119)

A checklist for respiratory pathogen pandemic preparedness planning

World Health Organization WHO (2023) C_WHO

This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.

Download (97)

View PDF (95)

Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential

World Health Organization WHO (2023) C_WHO

Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a... more

Our Recommendations

New Publications

Uso racional del equipo de protección personal frente a la COVID-19 y aspectos que considerar en situaciones de escasez graves recommended

Uso racional del equipo de protección personal frente a la COVID-19 y aspectos que considerar en situaciones de escasez graves
recommended